Jennifer A Kelly Selected Research

hydroxide ion

1/2022

Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jennifer A Kelly Research Topics

Disease

35	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 10/2006
15	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 02/2008
5	Inflammation (Inflammations) 12/2014 - 01/2010
4	Rheumatoid Arthritis 01/2022 - 03/2017
4	Lupus Nephritis 12/2014 - 04/2009
3	malar rash 01/2012 - 01/2011
2	Genetic Predisposition to Disease (Genetic Predisposition) 12/2015 - 01/2013
2	Lymphopenia (Lymphocytopenia) 01/2013 - 01/2012
2	Proteinuria 01/2012 - 01/2011
2	Nephritis 04/2009 - 02/2003
1	Genetic Risk Score 01/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2019
1	Sepsis (Septicemia) 01/2016
1	Rheumatic Diseases (Rheumatism) 01/2014
1	Disease Susceptibility (Diathesis) 06/2013
1	Oral Ulcer (Mouth Ulcer) 10/2011
1	Exanthema (Rash) 10/2011
1	Seizures (Absence Seizure) 01/2011
1	Hemolytic Anemia 01/2011
1	Arthritis (Polyarthritis) 01/2011
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 04/2009
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 02/2003
1	Serositis 02/2003
1	Thrombocytopenia (Thrombopenia) 02/2003

Drug/Important Bio-Agent (IBA)

10	AutoantibodiesIBA 01/2022 - 08/2009
6	InterferonsIBA 01/2020 - 04/2011
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 11/2010
4	AntibodiesIBA 11/2020 - 04/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 02/2003
3	Interferon-alpha (Interferon Alfa)IBA 01/2020 - 08/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 09/2012
3	Interferon Type IIBA 03/2017 - 01/2010
3	interleukin-21 (interleukin 21)IBA 10/2011 - 08/2009
2	P-2 (P 2)IBA 01/2020 - 02/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017 - 06/2013
2	CytokinesIBA 01/2016 - 01/2013
2	Interleukin-2 (IL2)IBA 09/2011 - 06/2011
1	Ubiquitin-Conjugating EnzymesIBA 01/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	25-hydroxyvitamin DIBA 01/2022
1	hydroxide ionIBA 01/2022
1	CCCTC-Binding FactorIBA 01/2022
1	ChromatinIBA 01/2020
1	Protein Glutamine gamma Glutamyltransferase 2IBA 04/2019
1	Cardiolipins (Cardiolipin)IBA 04/2019
1	Antiviral Agents (Antivirals)IBA 01/2017
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2016
1	LeptinIBA 12/2015
1	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 12/2014
1	Messenger RNA (mRNA)IBA 12/2014
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2014
1	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 12/2014
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2013
1	Mitogen-Activated Protein KinasesIBA 11/2013
1	Biological ProductsIBA 06/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2013
1	NucleolinIBA 01/2013
1	Interleukin-10 (Interleukin 10)IBA 01/2013
1	Nucleic AcidsIBA 01/2013
1	Toll-Like Receptor 7IBA 01/2013
1	Non-Receptor Type 22 Protein Tyrosine PhosphataseIBA 01/2013
1	3' Untranslated Regions (3' UTR)IBA 01/2013
1	AutoantigensIBA 04/2012
1	Complement Factor H (Factor H)IBA 05/2011
1	anti-dsDNA autoantibodyIBA 01/2011
1	HLA-DRB1 Chains (HLA DRB1)IBA 06/2010
1	AntigensIBA 06/2010
1	human MIRN663 microRNAIBA 05/2010
1	MicroRNAs (MicroRNA)IBA 05/2010
1	human MIRN638 microRNAIBA 05/2010
1	Biomarkers (Surrogate Marker)IBA 05/2010
1	interferon kappaIBA 01/2010
1	Interleukin-21 ReceptorsIBA 08/2009
1	Interleukin-1 Receptor-Associated KinasesIBA 04/2009
1	antiglomerular basement membrane antibodyIBA 04/2009
1	Serine (L-Serine)FDA Link 04/2009
1	Kallikreins (Kallikrein)IBA 04/2009
1	EsterasesIBA 04/2009
1	Interferon Regulatory FactorsIBA 08/2008
1	CD11b AntigenIBA 02/2008
1	Genetic Markers (Genetic Marker)IBA 10/2006
1	Antiphospholipid AntibodiesIBA 02/2003

Therapy/Procedure

1	Immunotherapy 01/2015